Compare ALEMBIC PHARMA with Sanofi India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA SANOFI INDIA ALEMBIC PHARMA/
SANOFI INDIA
 
P/E (TTM) x 18.0 42.2 42.5% View Chart
P/BV x 7.1 8.6 83.0% View Chart
Dividend Yield % 0.5 1.0 52.7%  

Financials

 ALEMBIC PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
SANOFI INDIA
Dec-18
ALEMBIC PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6646,840 9.7%   
Low Rs4124,630 8.9%   
Sales per share (Unadj.) Rs208.71,203.1 17.3%  
Earnings per share (Unadj.) Rs31.0165.3 18.8%  
Cash flow per share (Unadj.) Rs37.1209.9 17.7%  
Dividends per share (Unadj.) Rs5.5084.00 6.5%  
Dividend yield (eoy) %1.01.5 69.8%  
Book value per share (Unadj.) Rs144.2963.6 15.0%  
Shares outstanding (eoy) m188.5223.03 818.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.64.8 54.1%   
Avg P/E ratio x17.434.7 50.0%  
P/CF ratio (eoy) x14.527.3 53.1%  
Price / Book Value ratio x3.76.0 62.7%  
Dividend payout %17.750.8 34.9%   
Avg Mkt Cap Rs m101,461132,078 76.8%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m7,4674,068 183.6%   
Avg. sales/employee Rs ThNM8,393.8-  
Avg. wages/employee Rs ThNM1,232.4-  
Avg. net profit/employee Rs ThNM1,153.0-  
INCOME DATA
Net Sales Rs m39,34727,708 142.0%  
Other income Rs m94897 10.5%   
Total revenues Rs m39,44128,605 137.9%   
Gross profit Rs m8,7366,235 140.1%  
Depreciation Rs m1,1521,027 112.2%   
Interest Rs m1847 2,630.0%   
Profit before tax Rs m7,4936,098 122.9%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5682,292 68.4%   
Profit after tax Rs m5,8443,806 153.5%  
Gross profit margin %22.222.5 98.7%  
Effective tax rate %20.937.6 55.7%   
Net profit margin %14.913.7 108.1%  
BALANCE SHEET DATA
Current assets Rs m19,57715,922 123.0%   
Current liabilities Rs m14,8966,235 238.9%   
Net working cap to sales %11.935.0 34.0%  
Current ratio x1.32.6 51.5%  
Inventory Days Days9064 141.0%  
Debtors Days Days4521 217.3%  
Net fixed assets Rs m27,0977,539 359.4%   
Share capital Rs m377230 163.9%   
"Free" reserves Rs m26,81121,962 122.1%   
Net worth Rs m27,18822,192 122.5%   
Long term debt Rs m4,9930-   
Total assets Rs m47,77829,839 160.1%  
Interest coverage x41.7872.1 4.8%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.9 88.7%   
Return on assets %12.612.8 98.7%  
Return on equity %21.517.2 125.3%  
Return on capital %23.627.5 85.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4537,587 256.4%   
Fx outflow Rs m6,0657,145 84.9%   
Net fx Rs m13,388442 3,028.9%   
CASH FLOW
From Operations Rs m8,1203,739 217.2%  
From Investments Rs m-7,556-731 1,033.7%  
From Financial Activity Rs m590-1,972 -29.9%  
Net Cashflow Rs m1,1531,036 111.3%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 2.9 14.4 20.1%  
FIIs % 9.1 14.6 62.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 10.5 132.4%  
Shareholders   49,328 15,184 324.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  GSK PHARMA  UNICHEM LAB  ORCHID PHARMA  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Rallied 834 Points Today(Closing)

After staging a gap-up opening, Indian share markets extended gains as the session progressed and rallied nearly 2%, boosted by realty and finance stocks.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 19, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - WOCKHARDT COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS